|
Name |
Zygosporin E
|
| Molecular Formula | C30H37NO5 | |
| IUPAC Name* |
[(2R,3E,5S,7R,9E,12S,14S,16S)-16-benzyl-12-hydroxy-5,7,14-trimethyl-13-methylidene-6,18-dioxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-2-yl] acetate
|
|
| SMILES |
C[C@@H]1C/C=C/C2[C@@H](C(=C)[C@H](C3C2([C@@H](/C=C/[C@@H](C1=O)C)OC(=O)C)C(=O)N[C@H]3CC4=CC=CC=C4)C)O
|
|
| InChI |
InChI=1S/C30H37NO5/c1-17-10-9-13-23-28(34)20(4)19(3)26-24(16-22-11-7-6-8-12-22)31-29(35)30(23,26)25(36-21(5)32)15-14-18(2)27(17)33/h6-9,11-15,17-19,23-26,28,34H,4,10,16H2,1-3,5H3,(H,31,35)/b13-9+,15-14+/t17-,18+,19-,23?,24+,25-,26?,28-,30?/m1/s1
|
|
| InChIKey |
YOSIWRQXBHJIKL-KJRGTWELSA-N
|
|
| Synonyms |
Zygosporin E; 26399-27-9
|
|
| CAS | 26399-27-9 | |
| PubChem CID | 121596711 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 491.6 | ALogp: | 3.7 |
| HBD: | 2 | HBA: | 5 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 92.7 | Aromatic Rings: | 4 |
| Heavy Atoms: | 36 | QED Weighted: | 0.481 |
| Caco-2 Permeability: | -4.755 | MDCK Permeability: | 0.00005660 |
| Pgp-inhibitor: | 0.371 | Pgp-substrate: | 0.013 |
| Human Intestinal Absorption (HIA): | 0.196 | 20% Bioavailability (F20%): | 0.032 |
| 30% Bioavailability (F30%): | 0.004 |
| Blood-Brain-Barrier Penetration (BBB): | 0.798 | Plasma Protein Binding (PPB): | 91.49% |
| Volume Distribution (VD): | 0.979 | Fu: | 10.95% |
| CYP1A2-inhibitor: | 0.049 | CYP1A2-substrate: | 0.098 |
| CYP2C19-inhibitor: | 0.618 | CYP2C19-substrate: | 0.29 |
| CYP2C9-inhibitor: | 0.58 | CYP2C9-substrate: | 0.097 |
| CYP2D6-inhibitor: | 0.281 | CYP2D6-substrate: | 0.27 |
| CYP3A4-inhibitor: | 0.905 | CYP3A4-substrate: | 0.413 |
| Clearance (CL): | 5.328 | Half-life (T1/2): | 0.035 |
| hERG Blockers: | 0.146 | Human Hepatotoxicity (H-HT): | 0.798 |
| Drug-inuced Liver Injury (DILI): | 0.282 | AMES Toxicity: | 0.013 |
| Rat Oral Acute Toxicity: | 0.779 | Maximum Recommended Daily Dose: | 0.974 |
| Skin Sensitization: | 0.088 | Carcinogencity: | 0.132 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
| Respiratory Toxicity: | 0.972 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004026 | ![]() |
0.802 | D0V3ZA | ![]() |
0.254 | ||
| ENC005439 | ![]() |
0.766 | D09NNH | ![]() |
0.254 | ||
| ENC004341 | ![]() |
0.766 | D0SP3D | ![]() |
0.247 | ||
| ENC006059 | ![]() |
0.766 | D01TSI | ![]() |
0.247 | ||
| ENC002828 | ![]() |
0.761 | D0W7RJ | ![]() |
0.246 | ||
| ENC004745 | ![]() |
0.752 | D0R1BD | ![]() |
0.246 | ||
| ENC004468 | ![]() |
0.737 | D06CWH | ![]() |
0.245 | ||
| ENC003763 | ![]() |
0.692 | D0A5LH | ![]() |
0.243 | ||
| ENC005506 | ![]() |
0.692 | D0OB1J | ![]() |
0.241 | ||
| ENC005175 | ![]() |
0.692 | D0IN7I | ![]() |
0.241 | ||